Literature DB >> 32453687

Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.

Patrizia Accorsi1, Pierluigi Berti2, Vincenzo de Angelis3, Giustina De Silvestro4, Luca Mascaretti5, Angelo Ostuni6.   

Abstract

Passive immunotherapy with plasma derived from convalescent patients recovering from SARS-CoV-2 infection can be a promising approach in the treatment of COVID-19 patients. It is important that blood establishments are ready to satisfy requests for immune plasma by defining the requirements applicable to plasma donors and the standards for preparation, qualification, storage, distribution, and control of product use. This Position paper aims to give recommendations on the biological characteristics of a plasma preparation from convalescent donors and to support the evaluation of this therapeutic approach in more rigorous investigations.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32453687     DOI： 10.2450/2020.0124-20

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


  5 in total

1.  Position paper on the use of COVID-19 convalescent plasma: an update.

Authors:  Daniele Prati; Francesco Fiorin; Pierluigi Berti; Giustina De Silvestro; Patrizia Accorsi; Angelo Ostuni
Journal:  Blood Transfus       Date:  2021-05-21       Impact factor: 3.443

2.  Preparedness and activities of the anti-SARS-CoV-2 convalescent plasma bank in the Veneto region (Italy): An organizational model for future emergencies.

Authors:  Giustina De Silvestro; Giorgio Gandini; Francesco Fiorin; Piero Marson; Ersilia Barbone; Andrea Frigato; Gianluca Gessoni; Arianna Veronesi; Monia Pacenti; Monica Castelli; Marianna Rinaldi; Monica Rizzi; Francesca Stefani; Giovanni Roveroni
Journal:  Transfus Apher Sci       Date:  2021-05-07       Impact factor: 1.764

3.  Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization.

Authors:  P J Klasse; John P Moore
Journal:  Elife       Date:  2020-06-23       Impact factor: 8.140

Review 4.  Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic.

Authors:  Nandeeta Samad; Temitayo Eniola Sodunke; Hasan Al Banna; Ashmita Sapkota; Aneeka Nawar Fatema; Katia Iskandar; Dilshad Jahan; Timothy Craig Hardcastle; Tanzina Nusrat; Tajkera Sultana Chowdhury; Mainul Haque
Journal:  Risk Manag Healthc Policy       Date:  2020-11-23

Review 5.  Convalescent plasma - Is it useful for treating SARS Co-V2 infection?

Authors:  Sudha Ranganathan; Ranganathan N Iyer
Journal:  Indian J Med Microbiol       Date:  2020 Jul-Dec       Impact factor: 0.985
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.